Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodeling. A randomized open-label parallel study.

Cristian Domingo Ribas, R.M. Mirapeix, F. J. González-Barcala, Carles Forné, F. García

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

17 Cites (Scopus)

Accés al document

@article{f2454dbd3f7949128f7b6498c597b0b1,

title = "Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodeling. A randomized open-label parallel study.",

author = "\{Domingo Ribas\}, Cristian and R.M. Mirapeix and Gonz{\'a}lez-Barcala, \{F. J.\} and Carles Forn{\'e} and F. Garc{\'i}a",

year = "2023",

doi = "10.1007/s40265-023-01905-5",

language = "English",

journal = "Drugs",

issn = "0012-6667",

publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodeling. A randomized open-label parallel study.

AU - Domingo Ribas, Cristian

AU - Mirapeix, R.M.

AU - González-Barcala, F. J.

AU - Forné, Carles

AU - García, F.

PY - 2023

Y1 - 2023

UR - https://www.scopus.com/pages/publications/85164460390

U2 - 10.1007/s40265-023-01905-5

DO - 10.1007/s40265-023-01905-5

M3 - Article

C2 - 37436680

SN - 0012-6667

JO - Drugs

JF - Drugs

ER -